Companies / Turkey
Multinationals Eye Turkish Drug market
April 2006 | Company Finance AlertTurkey's drug market is attracting the attention of global investors after growing by 33% in 2005. US drugmaker Valeant is planning to launch its neurological products, while Sandoz - the generics division of Swiss drug firm Novartis - has recently decided to return to the market after a
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.



